Inventor
Rachael Clark
Inventor
Skipton, GB
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties24%
A61LMethods or apparatus for sterilising materials or objects in general18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A61KPreparations for medical, dental or toiletry purposes12%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms12%
A61FFilters implantable into blood vessels6%
C07KPeptides6%
C08LCompositions of macromolecular compounds6%
PatentTitleYear
9,849,182Wound treatment20179,404,931'Measurement of cytoskeletal proteins and uses thereof in diagnosis, prognosis and therapy'20168,834,905'Wound dressing compositions'20148,685,639'Diagnosis and prognosis of wound infection by measurement of a phospholipase A2 in wound fluid'20148,491,852'Marker of wound infection'20138,012,698'Diagnostic markers of wound infection'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2014Patents assigned to SYSTAGENIX WOUND MAN US INC (3)· patent assignee history
2011–2017Based in Skipton, GB· patent location history
2013–2016Patents assigned to CULLEN BREDA MARY (4)· patent assignee history
2013–2016Patents assigned to CLARK RACHAEL (3)· patent assignee history
2014–2017Patents assigned to CLARK RACHAEL LOUISE (2)· patent assignee history
2014–2016Patents assigned to SHAH FARAIA (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CULLEN BREDA MARY | 4 | 2013–2016 |
| CLARK RACHAELself | 3 | 2013–2016 |
| SYSTAGENIX WOUND MAN US INC | 3 | 2011–2014 |
| CLARK RACHAEL LOUISEself | 2 | 2014–2017 |
| SHAH FARAIA | 2 | 2014–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Skipton, GB | 6 | 2011–2017 |